If the company can sustain its revenue growth, the share pri...
If the company can sustain its revenue growth, the share price may further increase. The company's performance appears to have improved recently, as the one-year total shareholder return is better than the five-year total shareholder return.
Even Though Aurinia Pharmaceuticals (NASDAQ:AUPH) Has Lost US$63m Market Cap in Last 7 Days, Shareholders Are Still up 68% Over 1 Year
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment